Taking programmed cell death 180 degrees
February 22, 2011 by leonardzehr · Leave a Comment
While a linchpin of oncology research is inducing programmed cell death, or apoptosis, as a way of killing cancer cells, Cleveland BioLabs (NASDAQ:CBLI) is also trying to prevent cell death from occurring as an antidote for Acute Radiation Syndrome (ARS) and other acute stresses like the side effects of cancer treatment. “What differentiates us [...]
Listen to BioTuesdays 
